Ferulic Acid
CAS No. 1135-24-6
Ferulic Acid( Coniferic Acid | 4-hydroxy-3-Methoxycinnamic Acid | NSC 2821 | NSC 51986 | NSC 674320 )
Catalog No. M10474 CAS No. 1135-24-6
Ferulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Ferula assafoetida L. or Ligusticum chuanxiong.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 27 | In Stock |
|
100MG | 41 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFerulic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionFerulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Ferula assafoetida L. or Ligusticum chuanxiong.
-
DescriptionFerulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Ferula assafoetida L. or Ligusticum chuanxiong.(In Vitro):Ferulic acid (FA) is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively. Ferulic acid exhibits great inhibitory activity on FGFR1 with an inhibitory rate of 92% at 1 μM. The proliferation of HUVEC stimulated by FGF1 is markedly decreased after Ferulic acid treatment ranging from 5 to 40 μM for 24 h. Ferulic acid does not exert significant cell viability up to 20 μM, but over 30 μM Ferulic acid exhibits a cytotoxic effect in HUVEC compare to the control. Ferulic acid inhibits FGF1-induced HUVEC migration and invasion in a dose-dependent manner. Ferulic acid markedly suppresses the FGF1-induced phosphorylation of PI3K and Akt. Ferulic acid treatments significantly inhibit MMP-2 and MMP-9 expression stimulated by FGF1. (In Vivo):Treatment with Ferulic acid (FA) potently inhibits FGF1-induced neovascularization. It is found that intragastric administration of Ferulic acid markedly inhibits tumor volume and tumor weight, as compare to the counterparts treated with DMSO. Furthermore, Ferulic acid treatment is well tolerated, and there is no significant difference in weight between the vehicle group and the FA-treated groups. Ferulic acid (0.01, 0.1, 1 or 10 mg/kg) given by oral route decreases significantly the immobility time in the forced swimming test (FST) and tail suspension test (TST), whereas produces no effect in the open-field test. Results demonstrate that the administration of Ferulic acid (0.001 mg/kg, p.o.) boosts the antidepressant-like effect of fluoxetine (5 mg/kg, p.o.) in the TST.
-
In Vitro——
-
In Vivo——
-
SynonymsConiferic Acid | 4-hydroxy-3-Methoxycinnamic Acid | NSC 2821 | NSC 51986 | NSC 674320
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGFR1
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1135-24-6
-
Formula Weight194.19
-
Molecular FormulaC10H10O4
-
Purity>98% (HPLC)
-
SolubilityEthanol: 39 mg/mL (200.83 mM); DMSO: 39 mg/mL (200.83 mM)
-
SMILESO=C(O)/C=C/C1=CC=C(O)C(OC)=C1
-
Chemical Name(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yang GW, et al. Int J Mol Sci. 2015 Oct 12;16(10):24011-3
molnova catalog
related products
-
BLU9931
BLU9931 (BLU-9931) is a potent, selective, irreversible inhibitor of FGFR4 with IC50 of 3 nM.
-
AZD4547
A potent and selective inhibitor of FGFR1/2/3 with IC50s of 0.2/1.8/2.5 nM.
-
Infigratinib
Infigratinib (NVP-BGJ398, BGJ398) is a potent, selective pan-FGFR inhibitor.